Barbara Marengo

25PUBLICATIONS
51CO-AUTHORS
Molecular targetsChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Apr 14, 2026
Quaternary Phosphonium Salts Outperformed Vemurafenib (PLX) and Etoposide Against BRAFV600D,V600E PLX-Resistant Melanoma and MDR Neuroblastoma, Exhibiting No/Low Toxicity on 3T3/HaCaT Cells.

Silvana Alfei, Maria Grazia Signorello, Sara Tirendi

|Apr 14, 2026
Mechanisms Underlying Cancer Chemoresistance: A Starting Point to Identify New Anticancer Strategies.

Cinzia Domenicotti, Barbara Marengo

|Jan 28, 2026
Design and Synthesis of New Coumarin Hybrids Active Against Drug-Sensitive and Drug-Resistant Neuroblastoma Cells.

Carola Grondona, Barbara Marengo, Giulia Elda Valenti

|Oct 29, 2025
Antioxidant Food Supplementation in Cancer: Lessons from Clinical Trials and Insights from Preclinical Studies.

Alessandra Pulliero, Barbara Marengo, Oriana Ferrante

|Jul 12, 2025
Triazole-imidazo[1,2-b]pyrazoles Able to Counteract Melanoma Cell Survival Without Compromising the Viability of Healthy Keratinocytes.

Chiara Brullo, Barbara Marengo, Cinzia Domenicotti

|Jun 26, 2025
Targeting the p53/xCT/GSH Axis with PRIMA-1Met Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia.

Martina Pasino, Andrea Speciale, Silvia Ravera

Pageof 5

Frequent Collaborators

22 joint publications

Cinzia Domenicotti

11 joint publications

Giulia Elda Valenti

11 joint publications

Silvana Alfei

5 joint publications

Guendalina Zuccari